Lumos Pharma Inc (LUMO)
2.57
+0.05
(+1.98%)
USD |
NASDAQ |
May 22, 16:00
2.58
+0.01
(+0.39%)
After-Hours: 20:00
Lumos Pharma Price: 2.57 for May 22, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 22, 2024 | 2.516 | 2.660 | 2.516 | 2.57 | 6403.00 |
May 21, 2024 | 2.575 | 2.64 | 2.504 | 2.52 | 15150.00 |
May 20, 2024 | 2.65 | 2.695 | 2.515 | 2.62 | 51674.00 |
May 17, 2024 | 2.64 | 2.64 | 2.42 | 2.54 | 7451.00 |
May 16, 2024 | 2.22 | 2.67 | 2.22 | 2.63 | 44346.00 |
May 15, 2024 | 2.45 | 2.55 | 2.01 | 2.24 | 138072.0 |
May 14, 2024 | 2.80 | 2.888 | 2.44 | 2.55 | 85052.00 |
May 13, 2024 | 2.82 | 2.93 | 2.761 | 2.875 | 11233.00 |
May 10, 2024 | 3.05 | 3.05 | 2.73 | 2.90 | 32880.00 |
May 09, 2024 | 3.05 | 3.19 | 2.99 | 3.02 | 31555.00 |
May 08, 2024 | 2.98 | 3.03 | 2.96 | 3.000 | 12524.00 |
May 07, 2024 | 2.96 | 3.07 | 2.917 | 3.02 | 26542.00 |
May 06, 2024 | 3.05 | 3.05 | 2.91 | 3.00 | 43425.00 |
May 03, 2024 | 3.00 | 3.05 | 2.90 | 2.96 | 69636.00 |
May 02, 2024 | 3.05 | 3.06 | 2.98 | 3.04 | 128322.0 |
May 01, 2024 | 2.76 | 3.07 | 2.725 | 3.02 | 278322.0 |
Apr 30, 2024 | 2.81 | 2.90 | 2.70 | 2.81 | 19747.00 |
Apr 29, 2024 | 2.78 | 2.923 | 2.77 | 2.83 | 13699.00 |
Apr 26, 2024 | 2.744 | 2.78 | 2.744 | 2.77 | 688.00 |
Apr 25, 2024 | 2.713 | 2.81 | 2.713 | 2.76 | 1569.00 |
Apr 24, 2024 | 2.90 | 2.93 | 2.72 | 2.795 | 46348.00 |
Apr 23, 2024 | 2.73 | 2.85 | 2.70 | 2.80 | 17131.00 |
Apr 22, 2024 | 2.67 | 2.695 | 2.60 | 2.68 | 4652.00 |
Apr 19, 2024 | 2.65 | 2.83 | 2.53 | 2.59 | 12311.00 |
Apr 18, 2024 | 2.45 | 2.76 | 2.41 | 2.62 | 12387.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.24
Minimum
May 15 2024
35.91
Maximum
Dec 30 2020
9.452
Average
9.02
Median
Oct 25 2021
Price Benchmarks
icad Inc | 1.60 |
Perspective Therapeutics Inc | 1.49 |
Palatin Technologies Inc | 2.04 |
Bio-Path Holdings Inc | 2.12 |
Predictive Oncology Inc | 1.63 |
Price Related Metrics
PS Ratio | 9.389 |
PEG Ratio | -0.0242 |
Price to Book Value | 1.196 |
Earnings Yield | -213.2% |
Market Cap | 20.86M |
PEGY Ratio | -0.0242 |